CL2013003003A1 - Uso de fórmula infantil que comprende al menos una fuente de proteínas, una fuente de lípidos, una fuente de carbohidratos, con 1,6-1,85 g/100 kcal que sirve para preparar un medicamento útil en la prevención de la presión sanguínea elevada o de las enfermedades cardiovasculares. - Google Patents

Uso de fórmula infantil que comprende al menos una fuente de proteínas, una fuente de lípidos, una fuente de carbohidratos, con 1,6-1,85 g/100 kcal que sirve para preparar un medicamento útil en la prevención de la presión sanguínea elevada o de las enfermedades cardiovasculares.

Info

Publication number
CL2013003003A1
CL2013003003A1 CL2013003003A CL2013003003A CL2013003003A1 CL 2013003003 A1 CL2013003003 A1 CL 2013003003A1 CL 2013003003 A CL2013003003 A CL 2013003003A CL 2013003003 A CL2013003003 A CL 2013003003A CL 2013003003 A1 CL2013003003 A1 CL 2013003003A1
Authority
CL
Chile
Prior art keywords
source
kcal
carbohydrates
lipids
protein
Prior art date
Application number
CL2013003003A
Other languages
English (en)
Inventor
Catherine Mace
Philippe Steenhout
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45953168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013003003(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2013003003A1 publication Critical patent/CL2013003003A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CL2013003003A 2011-04-19 2013-10-16 Uso de fórmula infantil que comprende al menos una fuente de proteínas, una fuente de lípidos, una fuente de carbohidratos, con 1,6-1,85 g/100 kcal que sirve para preparar un medicamento útil en la prevención de la presión sanguínea elevada o de las enfermedades cardiovasculares. CL2013003003A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11163011A EP2514435A1 (en) 2011-04-19 2011-04-19 Infant formula for use in the prevention of cardiovascular diseases

Publications (1)

Publication Number Publication Date
CL2013003003A1 true CL2013003003A1 (es) 2014-04-21

Family

ID=45953168

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003003A CL2013003003A1 (es) 2011-04-19 2013-10-16 Uso de fórmula infantil que comprende al menos una fuente de proteínas, una fuente de lípidos, una fuente de carbohidratos, con 1,6-1,85 g/100 kcal que sirve para preparar un medicamento útil en la prevención de la presión sanguínea elevada o de las enfermedades cardiovasculares.

Country Status (13)

Country Link
US (1) US20140044830A1 (es)
EP (2) EP2514435A1 (es)
CN (1) CN103491973B (es)
AU (1) AU2012244798A1 (es)
BR (1) BR112013026573A2 (es)
CA (1) CA2831164A1 (es)
CL (1) CL2013003003A1 (es)
IL (1) IL228419A0 (es)
MX (1) MX2013011833A (es)
PH (1) PH12013501902A1 (es)
RU (1) RU2598707C2 (es)
SG (1) SG193934A1 (es)
WO (1) WO2012143362A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2839524C (en) 2011-06-20 2016-05-17 H.J. Heinz Company Probiotic compositions and methods
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US10058116B2 (en) * 2016-01-04 2018-08-28 Cari Genea Crossley Infant formula with improved nutritional value and digestive properties
RU2643765C1 (ru) * 2017-04-21 2018-02-05 Федеральное государственное автономное учреждение "Национальный научно-практический центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "ННПЦЗД" Минздрава России) Способ оптимизации нутритивного статуса у детей первого полугодия жизни с хронической сердечной недостаточностью
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN113226465A (zh) * 2018-12-19 2021-08-06 雀巢产品有限公司 用于预防或减少经皮水分流失并改善皮肤屏障功能的组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887436A (en) * 1956-05-28 1959-05-19 Pfizer & Co C Pharmaceutical compositions
CA2371696C (en) * 1999-04-29 2005-11-15 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
GB9923048D0 (en) 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
NZ544642A (en) * 2003-06-23 2009-01-31 Nestec Sa Infant or follow-on formula
CN101242748A (zh) * 2004-11-26 2008-08-13 荷兰纽迪希亚公司 含有蛋白酶抑制剂的婴儿营养品
MX2007007898A (es) * 2004-12-27 2007-08-20 Nestec Sa Uso de formula para lactantes con contenido de proteina reducido.
ES2350907T3 (es) * 2005-07-01 2011-01-28 N.V. Nutricia Nutrición para bebés con proteínas hidrolizadas.
US20070166354A1 (en) * 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
BRPI0620465A2 (pt) * 2005-12-23 2011-11-16 Nutricia Nv uso de uma composição
BRPI0712844A2 (pt) * 2006-06-13 2012-07-31 Nestec Sa prevenÇço e tratamento da otite mÉdia com cepas bacterianas nço patogÊnicas.
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
ATE541030T1 (de) * 2007-07-12 2012-01-15 Michael Laurence Murphy Hydroalkoholische fettemulsion und emulgator zur verwendung darin
EP2433507B1 (en) * 2007-11-26 2018-06-13 Nestec S.A. Age-tailored nutrition system for infants
US20110009359A1 (en) * 2007-12-21 2011-01-13 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
US20090311367A1 (en) * 2008-06-17 2009-12-17 Perry Stephen C Dietary Supplement
MY159212A (en) * 2008-09-02 2016-12-30 Nutricia Nv Nutritional compositions with coated lipid globules
WO2010070613A2 (en) * 2008-12-18 2010-06-24 University College London Baby feeding formula and system
BRPI0924051A2 (pt) * 2009-01-19 2015-07-21 Nestec Sa Composição nutricional para lactente
US9480670B2 (en) * 2009-04-01 2016-11-01 Nestec S.A. Reduction of risk of obesity
EP2413952B2 (en) * 2009-04-03 2019-10-02 Société des Produits Nestlé S.A. Improvement in promotion of healthy catch-up growth
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant

Also Published As

Publication number Publication date
RU2013151165A (ru) 2015-05-27
AU2012244798A1 (en) 2013-10-03
EP2699251A1 (en) 2014-02-26
EP2699251B1 (en) 2017-03-22
EP2514435A1 (en) 2012-10-24
MX2013011833A (es) 2013-11-01
CN103491973B (zh) 2016-09-14
RU2598707C2 (ru) 2016-09-27
BR112013026573A2 (pt) 2016-09-06
IL228419A0 (en) 2013-12-31
PH12013501902A1 (en) 2013-10-14
CN103491973A (zh) 2014-01-01
SG193934A1 (en) 2013-11-29
US20140044830A1 (en) 2014-02-13
WO2012143362A1 (en) 2012-10-26
CA2831164A1 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
CL2017000830A1 (es) Formulación estable que comprende un azúcar no reductora, un anticuerpo anti-s4b7 y al menos un aminoácido libre; un método para preparar dicha formulación; uso de dicha formulación para tratar una enfermedad inflamatoria del intestino.
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
ECSP12012125A (es) Ariltriazolonas ligadas a bisarilo y su uso
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
DOP2015000246A (es) Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares
GT201300243A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
HUE043540T2 (hu) Szubsztituált dimer kinazolin-származék, elõállítása, valamint alkalmazása 1-es és 2-es típusú cukorbetegség kezelésére szolgáló gyógyászati készítményekben
CL2016001120A1 (es) Compuestos derivados de pirrolo1,2-f1,2,4triazina ,composición farmacéutica que los comprende y su uso en el tratamiento de una infección por virus sincicial compuestos intermediarios. pct
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
BR112015017251A8 (pt) composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas
BR112013015634B8 (pt) composição que compreende gordura, proteína e carboidratos, uso da composição, uso de fibras alimentares, processo para preparação de uma fórmula infantil e processo para preparação da composição
PH12013501902A1 (en) Infant formula for use in the prevention of cardiovascular diseases
UA115811C2 (uk) Стабільний розчин об'єднаних баклофену, сорбіту і налтрексону для перорального застосування
BR112015008389A2 (pt) compostos úteis na síntese de compostos de benzamida
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
DOP2016000076A (es) Tienouracilcarboxamidas cíclicas y usos de las mismas
BR112014000795A2 (pt) uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias
MX2014006574A (es) Formulaciones de acamprosato, metodos de uso de las mismas, y combinaciones que comprenden las mismas.
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
DOP2015000175A (es) Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular
CL2013000021A1 (es) Forma cristalina delta de la sal de arginina de perindoprilo; procedimiento de preparacion; composiciones farmaceuticas que la contienen; y su uso par el tratamiento de las enfermedades cardiovasculares, tales como hipertension arterial, insuficiencia cardiaca o enfermedad coronaria estable.
BR112015026196A2 (pt) contentor de remessa e conector forkstrap para o mesmo